Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - clonazepam -

Australia - English - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - cyclopentolate hydrochloride, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: potassium chloride; purified water; hydrochloric acid; benzalkonium chloride; boric acid; disodium edetate; sodium carbonate monohydrate - indications as at 27 june 1996: for mydriasis nad cycloplegia in diagnostic procedures. for some pre- and post-operative states when mydriasis is required and when a shorter acting mydriatic and cycloplegic is needed in the therapy of iridocyclitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciprofloxacin hydrochloride, quantity: 3.5 mg/ml (equivalent: ciprofloxacin, qty 3 mg/ml) - ear drops, solution - excipient ingredients: purified water; sodium acetate; mannitol; hydrochloric acid; glacial acetic acid; benzalkonium chloride; disodium edetate; sodium hydroxide - treatment of chronic suppurative otitis media caused by organisms susceptible to ciprofloxacin in adults and children one month of age or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciprofloxacin hydrochloride, quantity: 3.5 mg/ml (equivalent: ciprofloxacin, qty 3 mg/ml) - ear drops, solution - excipient ingredients: mannitol; purified water; benzalkonium chloride; sodium hydroxide; disodium edetate; sodium acetate; hydrochloric acid; glacial acetic acid - treatment of chronic suppurative otitis media caused by organisms susceptible to ciprofloxacin in adults and children one month of age or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciprofloxacin hydrochloride, quantity: 3.5 mg/ml (equivalent: ciprofloxacin, qty 3 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; mannitol; sodium hydroxide; purified water; hydrochloric acid; disodium edetate; glacial acetic acid; sodium acetate - treatment of bacterial keratitis (infected corneal ulcers) and severe bacterial conjunctivitis caused by organisms susceptible to ciprofloxacin in adults and children 12 months of age or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciprofloxacin hydrochloride, quantity: 3.5 mg/ml (equivalent: ciprofloxacin, qty 3 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; benzalkonium chloride; sodium acetate; glacial acetic acid; purified water; disodium edetate; hydrochloric acid; mannitol - treatment of bacterial keratitis (infected corneal ulcers) and severe bacterial conjuctivitis caused by organisms susceptible to ciprofloxacin. indications as at 25 july 1996: treatment of bacterial keratitis (infected corneal ulcers) and severe bacterial conjunctivitis caused by organisms susceptible to ciprofloxacin in adults and children 12 months of age or older.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

diamond pharma - levofloxacin (levofloxacin hemihydrate) - drops eye - 5mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

aidacare pty ltd - 35563 - bariatric bed - bariatric ward bed designed to be used in hospital and clinical environments. this device has a high safe working load (kg) allowing for obese and bariatric patients. this device runs off mains power and may be fitted with accessories to further improve its performance.

Australia - English - Department of Health (Therapeutic Goods Administration)

ah essential limited - 37954 - bariatric walker, non-foldable - bariatric walker foldable an all- or partially-wheeled mobility aid in the form of a pulpit or hand grip style support structure to provide a stable support to a bariatric patient with a disability, a geriatric or an infirm person when standing or ambulating; it may also be used during rehabilitation. it is constructed of lightweight metal, plastic, and rubber materials and in the form of a mobile support structure which the user holds and pushes in front of them as they walk.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn bhd - clonazepam -